Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
iShares Russell 2000 ETF
(NY:
IWM
)
223.08
+2.05 (+0.93%)
Official Closing Price
Updated: 5:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about iShares Russell 2000 ETF
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Tesla Rebounds While Tariffs Weigh On Manufacturing: What's Driving Markets Monday?
March 03, 2025
Stocks fell broadly on Monday to start the month of March with all three major indices red in midday trading. Investors digested a decline in February's ISM Manufacturing PMI data which fell to 50.3%,...
Via
Benzinga
Amidst Elevated Valuations, Macro/Policy Uncertainty, Relief Rally Possible In Equities
March 03, 2025
The S&P 500 trades at elevated multiples. Earnings expectations for this year and next are very high. Enter macro uncertainty surrounding the fiscal/tariff policy of the Trump administration.
Via
Talk Markets
Topics
Bonds
Government
Stocks
Retail Traders Divided On March Market Moves After February Dip — Most Want To Sit Out Or Go For Buffett-Style Cash Play
March 03, 2025
The potential impact from President Donald Trump’s tariffs, the continuing uncertainty surrounding the Federal Reserve rate outlook and mixed earnings served as pushbacks in February.
Via
Stocktwits
Topics
Economy
Government
World Trade
Crucial Fibonacci Level
February 27, 2025
In this article, we shall review the latest chart of Russell 2000/RTY Futures.
Via
Talk Markets
Topics
Stocks / Equities
Alto Neuroscience Is Down Nearly 35% This Year, But Retail Traders Keep Flocking To Micro-Cap Stock
March 03, 2025
While ALTO-100's Phase 2 results failed to meet expectations, the company has emphasized the potential of ALTO-300, another MDD treatment currently in Phase 2b trials.
Via
Stocktwits
Nasdaq Tests 200-Day MA As Russell 2000 Breaks Weekly Trend Support
March 02, 2025
The Russell 2000 broke below support of the rising channel on the weekly time frame. Meanwhile, the Nasdaq finished the week with a bullish piercing pattern following a successful test of the 200-day...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Semiconductors Fail A Key Support Level - And More
March 02, 2025
It has been 2 years and 2 months since the ETF for Semiconductors SMH has traded below the 50-week moving average.
Via
Talk Markets
Topics
ETFs
Peek Into The Future Thru Futures, Hedge Fund Positions - March 2
March 02, 2025
Since September last year, 23 – or thereabouts – has posed difficulty for volatility bulls, and this trend prevailed this week as well. VIX for now is probably headed lower.
Via
Talk Markets
Topics
Bonds
Currencies/Forex
Stocks
Powerful UnR Session As All Four Market Indices Lockstep Rally Into The Close; Bear Trap Set?
February 28, 2025
In this video lesson, I review the overall market, the recent bearish sentiment, and one new swing trade idea for Monday's session.
Via
Talk Markets
Topics
Stocks / Equities
Market Meltdown Or Bounce Back? Here’s What Traders Need To Know
February 28, 2025
As February draws to a close, markets remain volatile amid shifting macroeconomic conditions, geopolitical tensions, and sector-specific developments.
Via
Talk Markets
Topics
Stocks / Equities
Buckle Up, This Bull Market Might Be Ending
February 28, 2025
The markets are setting up for a big test.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?
February 28, 2025
Stocks recovered on Friday, with all three major indexes in the green, as the tech sector bounced back from Thursday's losses with NVIDIA Corp. (NASDAQ:NVDA) up 1.37% and Tesla, Inc. (NASDAQ:TSLA)
Via
Benzinga
IWM ETF: Russell 2000 Crashes As Fear And Greed Index Tumbles
February 28, 2025
The Russell 2000 index crashed for the second consecutive week as the fear and greed index moved to the extreme fear level.
Via
Talk Markets
Topics
ETFs
PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?
February 28, 2025
The rally follows PepGen's release of early clinical data from its Phase 1 trial evaluating its therapy to treat a rare genetic disorder.
Via
Stocktwits
Altimmune Retail Buzz Heats Up On MASH Progress, FDA Nod For New Trials: Stock Jumps After Q4 Print
February 27, 2025
The company plans to unveil details at its virtual R&D Day on March 13.
Via
Stocktwits
Russell 2000 Earnings Dashboard 24Q4 - Thursday, Feb. 27
February 27, 2025
The 24Q4 Y/Y blended earnings growth estimate is 55.3%. If the energy sector is excluded, the growth rate for the index is 85.5%.
Via
Talk Markets
Topics
Stocks / Equities
Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday?
February 27, 2025
The S&P 500 and Nasdaq both slipped into the red, reversing early gains on Thursday, while the Dow Jones remained in positive territory in midday trading.
Via
Benzinga
Topics
Government
Stocks
AMC Vs. Cinemark: Retail Picks Potential Winner Among Movie Theater Chain Stocks
February 27, 2025
AMC and Cinemark reported record revenues for the fourth quarter, fueled by moviegoers’ return to theaters in droves.
Via
Stocktwits
IonQ Announces Mixed Q4 Results, $500M At-the-Market Stock Offering - Stock Slips But Retail Support Stays Strong
February 27, 2025
New bookings totaled $22.7 million for the fourth quarter and $95.6 million for the full year, exceeding the guidance of $75 million to $95 million.
Via
Stocktwits
Bloomin’ Brands Stock Dives To One-Year Low After Q4 Revenue Fall: Retail Sentiment Turns Gloomy
February 27, 2025
Sentiment on Stocktwits turned ‘bearish’ compared to ‘bullish’ a week ago
Via
Stocktwits
MannKind Stock Surges After-Hours On Q4 Revenue Beat, Debt Reduction As Retail Investors Celebrate ‘Amazing Comeback’
February 27, 2025
The company significantly reduced its debt principal by $236 million, leaving just $36 million in remaining convertible debt, and ended 2024 with $203 million in cash, cash equivalents, and...
Via
Stocktwits
Nasdaq And Russell 2000 Test January Support And Go "Meh"
February 26, 2025
Not a whole lot of positivity to today, even though support held.
Via
Talk Markets
Topics
Stocks / Equities
Nvidia Earnings On Deck, SMCI Regains Compliance: What's Driving Markets Wednesday?
February 26, 2025
All three major indices were green in midday trading Wednesday as the S&P 500 and Nasdaq 100 looked to snap their four-day losing streaks. NVIDIA Corp.
Via
Benzinga
Golden Ocean CEO Says Company Using Current Market Weakness To Upgrade Fleet: Retail Sentiment Hits Year-High After Q4 Beat
February 26, 2025
Revenue declined 17% year-over-year to $210.97 million but topped an analyst projection of $176.64 million.
Via
Stocktwits
Cava Group's FY25 Guidance Is 'Very Achievable,' Says Gary Black Despite Mixed Q4: 'Economic Model Is Powerful,' Says CFO
February 26, 2025
Restaurant chain owner CAVA Group reported a mixed fourth quarter and issued conservative guidance for the next fiscal year.
Via
Benzinga
Arcutis Biotherapeutics Sees 400% Spike In Retail Buzz As Q4 Beat Fuels After-Hours Rally
February 26, 2025
Sales of Zoryve, Arcutis' leading dermatology drug, surged 413% year-over-year to $69.4 million, a 55% increase from the previous quarter.
Via
Stocktwits
Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday?
February 25, 2025
Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a...
Via
Benzinga
Topics
Stocks
What Has The Market Accomplished?
February 25, 2025
Equities have taken a series of body blows in the three trading days since Wednesday’s high, the S&P 500 looked likely to make it to the end of the day yesterday and hold above its 50-day moving...
Via
Talk Markets
Topics
ETFs
Stocks
Summit Therapeutics’ Retail Chatter Explodes As Pfizer Trial Pact Drowns Out Q4 Letdown
February 24, 2025
Message volume on Stocktwits jumped 2,500%, with retail traders focusing on Summit’s partnership to evaluate ivonescimab in combination with Pfizer’s antibody-drug conjugates for solid tumors.
Via
Stocktwits
You Win Some - You Lose Lots
February 24, 2025
The S&P had started to clear resistance, posting new all-time highs before sellers struck with avengence.
Via
Talk Markets
Topics
Stocks
Stocks / Equities
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.